Eli Lilly and Company (ETR:LLY)
906.20
-2.60 (-0.29%)
At close: Dec 22, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€1,077,521
Profits / Employee
€333,886
Market Cap
819.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Eli Lilly and Company News
- 9 hours ago - Noteworthy Monday Option Activity: LLY, ORCL, GMED - Nasdaq
- 15 hours ago - A Congress Member Bought Up To $30K In Eaton Corp Stock: Here's What You Need To Know - Benzinga
- 16 hours ago - Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Nasdaq
- 19 hours ago - ABVX Stock Jumps on Takeover Speculation by Eli Lilly - GuruFocus
- 1 day ago - These are the world's most important stocks heading into 2026, according to Bank of America - CNBC
- 2 days ago - Our Top 10 High-Growth Dividend Stocks - December 2025 - Seeking Alpha
- 3 days ago - David Burrows' Top Picks: Rio Tinto, Eli Lilly & Tesla - BNN Bloomberg
- 3 days ago - Watch live: Trump to deliver announcement on drug pricing - The Hill